Contents
Recent Patents on CNS Drug Discovery (Discontinued), Volume 2 - Number 2
Advances in the Discovery of Novel Positive Allosteric Modulators of the α7 Nicotinic Acetylcholine Receptor
, 2(2): 99 - 106Ramin Faghih, Gregory A. Gfesser and Murali Gopalakrishnan
DOI: 10.2174/157488907780832751
GPCR Drug Discovery: Novel Ligands for CNS Receptors
, 2(2): 107 - 112William K. Lim
DOI: 10.2174/157488907780832689
Cutting-edge Patents in Alzheimers Disease Drug Discovery: Anticipation of Potential Future Treatments
, 2(2): 113 - 123Laurent Lecanu and Vassilios Papadopoulos
DOI: 10.2174/157488907780832715
The Gastrin-Releasing Peptide Receptor as a Therapeutic Target in Central Nervous System Disorders
, 2(2): 125 - 129Rafael Roesler, Flavio Kapczinski, Joao Quevedo, Felipe Dal Pizzol and Gilberto Schwartsmann
DOI: 10.2174/157488907780832742
The Seek of Neuroprotection: Introducing Cannabinoids
, 2(2): 131 - 139Jose Martinez-Orgado, David Fernandez-Lopez, IgnacioLizasoain and Julian Romero
DOI: 10.2174/157488907780832724
The Experience of Combining Agents, Specially Triptans and Non Steroidal Anti-Inflammatory Drugs, for the Acute Treatment of Migraine - A Review
, 2(2): 141 - 144Abouch V. Krymchantowski and Carla da C. Jevoux
DOI: 10.2174/157488907780832733
Protective Substances Against Zinc-Induced Neuronal Death after Ischemia:Carnosine as a Target for Drug of Vascular Type of Dementia
, 2(2): 145 - 149Masahiro Kawahara, Keiko Konoha, Tetsuya Nagata and Yutaka Sadakane
DOI: 10.2174/157488907780832698
Dexmedetomidine: A Novel Anesthetic Agent for Middle Ear Surgery
, 2(2): 151 - 154Yezdan Firat and Erol Selimoglu
DOI: 10.2174/157488907780832760
Webmaster Contact: info@benthamscience.org